Relationship between Th17 immune response and cancer

HS Marques, BB de Brito, FAF da Silva… - World Journal of …, 2021 - pmc.ncbi.nlm.nih.gov
Cancer is the second leading cause of death worldwide and epidemiological projections
predict growing cancer mortality rates in the next decades. Cancer has a close relationship …

Predictive and prognostic relevance of tumor-infiltrating immune cells: tailoring personalized treatments against different cancer types

TC Dakal, N George, C Xu, P Suravajhala, A Kumar - Cancers, 2024 - mdpi.com
Simple Summary This review summarizes the pivotal role of tumor-infiltrating immune cells
(TIICs) within the tumor microenvironment (TME) and their impact on cancer prognosis and …

Saikosaponin A inhibits breast cancer by regulating Th1/Th2 balance

X Zhao, J Liu, S Ge, C Chen, S Li, X Wu… - Frontiers in …, 2019 - frontiersin.org
Saikosaponin A (SSa) is isolated from the dried root of Radix Bupleuri, an herb widely used
in traditional Chinese medicine, exerting antitumor activities. The T helper cell type 1 …

Deep-learning–based characterization of tumor-infiltrating lymphocytes in breast cancers from histopathology images and multiomics data

Z Lu, S Xu, W Shao, Y Wu, J Zhang, Z Han… - JCO clinical cancer …, 2020 - ascopubs.org
PURPOSE Tumor-infiltrating lymphocytes (TILs) and their spatial characterizations on whole-
slide images (WSIs) of histopathology sections have become crucial in diagnosis, prognosis …

Advances in research on immune escape mechanism of glioma

X Guo, G Wang - CNS Neuroscience & Therapeutics, 2023 - Wiley Online Library
Background Glioma is the most common primary intracranial malignancy in clinical practice,
and in particular, IDH‐wildtype glioblastoma has the worst prognosis. In recent years …

Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile

G Avalos-Navarro, JF Muñoz-Valle… - Clinical and …, 2019 - Springer
Breast cancer (BC) is a health problem worldwide; there is evidence that inflammatory
cytokines are increased in BC. Macrophage migration inhibitory factor (MIF) has multiple …

[HTML][HTML] Morphologic and molecular features of breast ductal carcinoma in situ

S Sanati - The American journal of pathology, 2019 - Elsevier
Ductal carcinoma in situ (DCIS) encompasses a highly heterogeneous group of lesions that
differ with regard to their clinical presentations, histologic features, biomarker profiles …

Higher densities of tumour‐infiltrating lymphocytes and CD4+ T cells predict recurrence and progression of ductal carcinoma in situ of the breast

AA Thike, X Chen, VCY Koh, ND Binte Md Nasir… - …, 2020 - Wiley Online Library
Aims Host immunity influences cancer progression and therapeutic response. We
investigated the potential of tumour‐infiltrating lymphocytes (TIL s) around ductal carcinoma …

[PDF][PDF] Exploring public cancer gene expression signatures across bulk, single-cell and spatial transcriptomics data with signifinder Bioconductor package

S Pirrotta, L Masatti, A Bortolato, A Corrà… - NAR Genomics and …, 2024 - academic.oup.com
Understanding cancer mechanisms, defining subtypes, predicting prognosis and assessing
therapy efficacy are crucial aspects of cancer research. Gene-expression signatures derived …

Interobserver variability in ductal carcinoma in situ of the breast

MR Van Bockstal, M Berlière… - American journal of …, 2020 - academic.oup.com
Objectives Since most patients with ductal carcinoma in situ (DCIS) of the breast are treated
upon diagnosis, evidence on its natural progression to invasive carcinoma is limited. It is …